Back to search

Article

Hydroxychloroquine as Prophylactic Adjunct to BCG Vaccination in High-Risk Neonates: A Hypothesis for Triple Efficacy in Tuberculosis Prevention, BCG-Complication Mitigation, and SCID Safety

2026-03-18

Abstract excerpt

<h4>Background: </h4> BCG vaccination at birth remains the cornerstone of neonatal tuberculosis (TB) protection in high-burden countries. However, BCG induces severe, potentially fatal disseminated infection (BCGosis) in infants with Severe Combined Immunodeficiency (SCID). Saudi Arabia's 2019 policy delay of BCG to six months of age—intended to reduce BCGitis in SCID—leaves the vast immunocompetent neonatal popul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
57cab872-362f-5133-aa45-56a622fc49b1
DOI
10.20944/preprints202603.1422.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hydroxychloroquine as Prophylactic Adjunct to BCG Vaccination in High-Risk Neonates: A Hypothesis for Triple Efficacy in Tuberculosis Prevention, BCG-Complication Mitigation, and SCID SafetyDOI 10.20944/preprints202603.1422.v1
Select a neighboring publication to make it the new centre.